Broadly neutralizing antibodies (bnAbs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Broadly neutralizing antibodies (bnAbs), covering 2025-03-25 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption [Phase 1]